0001209191-18-045745.txt : 20180807 0001209191-18-045745.hdr.sgml : 20180807 20180807175356 ACCESSION NUMBER: 0001209191-18-045745 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180806 FILED AS OF DATE: 20180807 DATE AS OF CHANGE: 20180807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cavanagh Shawn CENTRAL INDEX KEY: 0001353221 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 18999326 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: EAST RUTHERFORD STATE: NJ ZIP: 07073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-06 0 0000820081 CAMBREX CORP CBM 0001353221 Cavanagh Shawn ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073 0 1 0 0 EVP & COO Common Stock 2018-08-06 4 M 0 10000 16.905 A 27658 D Common Stock 2018-08-06 4 M 0 10000 17.81 A 37658 D Common Stock 2018-08-06 4 M 0 17500 41.355 A 55158 D Common Stock 2018-08-06 4 M 0 399 40.65 A 55557 D Common Stock 2018-08-06 4 S 0 29155 62.11 D 26402 D Common Stock 2018-08-06 4 S 0 8744 63.16 D 17658 D Common Stock 2018-08-07 4 M 0 8351 40.65 A 26009 D Common Stock 2018-08-07 4 S 0 8351 62.89 D 17658 D Stock Option (right to buy) 16.905 2018-08-06 4 M 0 10000 0.00 A 2020-10-28 Common Stock 10000 0 D Stock Option (right to buy) 17.81 2018-08-06 4 M 0 10000 0.00 A 2021-10-22 Common Stock 10000 10000 D Stock Option (right to buy) 41.355 2018-08-06 4 M 0 17500 0.00 A 2022-10-21 Common Stock 17500 17500 D Stock Option (right to buy) 40.65 2018-08-06 4 M 0 399 0.00 A 2023-10-26 Common Stock 399 34601 D Stock Option (right to buy) 40.65 2018-08-07 4 M 0 8351 0.00 A 2023-10-26 Common Stock 8351 26250 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.65 to $62.65 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $63.50 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4. The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted. The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted. The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted. /s/ Samantha Hanley for Shawn Cavanagh by POA 2018-08-07